ENTRY       D03362                      Drug
NAME        Trafermin (USAN/INN);
            Trafermin (genetical recombination) (JAN);
            Fiblast (TN)
FORMULA     C764H1201N217O219S6
EXACT_MASS  17111.7836
MOL_WEIGHT  17122.4232
REMARK      Therapeutic category: 1329 2699 2790
            ATC code: D03AX15
            Product: D03362<JP>
EFFICACY    Anti-ulcerative (skin), Periodontal guided tissue regeneraion agent, Stroke treatment
COMMENT     Fibroblast growth factor
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS
               D03A CICATRIZANTS
                D03AX Other cicatrizants
                 D03AX15 Trafermin
                  D03362  Trafermin (USAN/INN) &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              13  Agents affecting sensory organs
               132  Otic and nasal agents
                1329  Others
                 D03362  Trafermin (USAN/INN); Trafermin (genetical recombination) (JAN)
             2  Agents affecting individual organs
              26  Epidermides
               269  Miscellaneous
                2699  Others
                 D03362  Trafermin (USAN/INN); Trafermin (genetical recombination) (JAN)
              27  Dental preparations
               279  Miscellaneous
                2790  Miscellaneous
                 D03362  Trafermin (USAN/INN); Trafermin (genetical recombination) (JAN)
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D03362
DBLINKS     CAS: 131094-16-1
            PubChem: 17397511
            NIKKAJI: J2.194.593E
///
